Predicting therapy-related myeloid neoplasms after CAR-T with the Clonal Haematopoiesis Risk Score (CHRS).
Galli E, Rossi M, Pansini I, Viscovo M, Malara T, Colangelo M, Alma E, Valentini CG, Teofili L, Hohaus S, Sica S, Sorà F, Chiusolo P.
Galli E, et al. Among authors: sica s.
Br J Haematol. 2024 Nov 13. doi: 10.1111/bjh.19905. Online ahead of print.
Br J Haematol. 2024.
PMID: 39539012